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a  b  s  t  r  a  c  t
Stakeholder  engagement  in  health  policy  research  is often  said to increase  ‘research  impact’,  but  the  active
role of  stakeholders  in  creating  impact  remains  underexplored.  We  explored  how  stakeholders  shaped  the
translation  of  health  policy  research  into  action.  Our  comparative  case-study  tracked  a European  research
project  that  aimed  to transfer  an existing  tobacco  control  return  on investment  tool.  That  project  also
aimed  to increase  its  impact  by  engaging  with  stakeholders  in  further  developing  the tool.  We  conducted
semi-structured  interviews,  using  an  actor-scenario  mapping  approach.  Actor-scenarios  can  be  seen  as
relational  descriptions  of a future  world.  We  mapped  the  scenarios  by  asking  stakeholders  to describe
who  and  what  would  play  a  role  in  the  tool’s  utilisation.  Our results  show  that  stakeholders  envisioned
disparate  futures  for the  tool.  Some  scenarios  were  speciﬁc,  whereas  most  were  generic  projections  of
abstract  potential  users  and  responsibilities.  We  show  how  stakeholders  mobilised  elements  of context,
such  as  legislative  support  and  agricultural  practice,  that  would  affect  the  tool’s  use. We  conclude  that
stakeholders  shape  knowledge  translation  processes  by  continuously  putting  forth  explicit  or  implicit
scenarios  about  the  future.  Mapping  actor-scenarios  may  help  in aligning  knowledge  production  with
utilisation.  Insights  into  potential  roles  and  responsibilities  could  be  fed  back  in research  projects  with
the  aim  of  increasing  the  likelihood  that  the study  results  may  be  used.
©  2019  The  Author(s).  Published  by Elsevier  B.V. This  is  an open  access  article  under  the CC  BY  license. Introduction
The practice of stakeholder engagement in knowledge produc-
ion is gaining increasing traction in research funding debates [1–3].
ne of the principal reasons for engaging stakeholders is that it
ight increase the likelihood that research outputs will be used
4,5]. In practice, researchers often retrospectively attribute the use
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of their ﬁndings to their engagement with stakeholders [6]. Others
emphasise the importance of prospectively exploring how stake-
holder engagement processes evolve and affect the translation of
knowledge into action [7]. How stakeholder engagement shapes
the use of knowledge, and which roles stakeholders play in this,
had been largely underexplored [8,9].
The literature suggest that stakeholder engagement affects
knowledge translation in different ways. First, stakeholders may
add valuable knowledge and skills to the research process [10,11].
Second, stakeholders possess experiential information about the
environment in which the research ﬁndings might be used. Such
information can be used to align the research process with the envi-
ronment in which the research ﬁndings could be used [7]. Third,
by being engaged, stakeholders gain a better understanding of the
prospective study results. This would inform the stakeholders of
 under the CC BY license (http://creativecommons.org/licenses/by/4.0/).




























































Box 1: Description of the SEE-Impact study in relation
to the EC-funded EQUIPT project
Studying engagement in the development of a tobacco-
control tool
The project under study was funded through the Euro-
pean Commission’s Seventh Framework Programme. The
European-study on Quantifying Utility of Investment in Pro-
tection from Tobacco (EQUIPT) was a collaboration between
11 members from seven countries (i.e. Belgium, Croatia,
Germany, Hungary, the Netherlands, Spain, and the UK), and
was led by the Health Economics Research Group (HERG) from
Brunel University London. The project commenced in October
2013 and ended September 2016. Their aim was to assess
the “cross-context transferability of economic evidence on
tobacco control” which led them to further develop an existing
ROI tool for use in other EU countries. As part of their project,
they tested the tool in the Netherlands, Germany, Spain, and
Hungary [28].
The existing tool had been developed in the UK by the
HERG in conjunction with the National Institute for Health
and Care Excellence (NICE) and is available on the NICE web-
site (http://bit.ly/tobacco-roi). The tool allows users to calculate
savings for every monetary unit invested in certain tobacco-
control or smoking cessation interventions. The stakeholder
engagement in the EQUIPT project was informed by the suc-
cessful stakeholder engagement in the original UK project.
This had contributed to the original ROI tool becoming the
NICE’s support tool for English local authorities, which even-
tually informed the smoking cessation approaches of several
local authorities.
The qualitative case-study presented in this paper was part
of the Stakeholder Engagement in EQUIPT for Impact (SEE-
Impact) study, funded by the Medical Research Council in
the United Kingdom. SEE-Impact prospectively tracked all
stakeholder engagement activities in EQUIPT with the aim of
describing to what extent engagement affects research impact.18 R.A.J. Borst et al. / Healt
he study taking place, but also encourages them to think about
otential use of the results in practice [12,13]. Finally, engage-
ent can establish a trust-relationship between researchers and
otential users. Trust is essential for mutual understanding and
ommunication between actors and increases the presumed legiti-
acy of results [14,15]. Oliver, Kothari and Mays [16] conclude that
takeholder engagement is generally considered to make a positive
ontribution to research projects, but may  induce challenges and
osts as well. In particular, they call for more reﬂection on when to
ngage stakeholders in research and in what way [16].
Science and technology studies (STS) emerged as a constructivist
nterdisciplinary ﬁeld in the late 1970s and is known for study-
ng knowledge production practices and the role that users play
n these processes [17–19]. It seems particularly well equipped
o reﬂect on the role of stakeholder engagement in health pol-
cy research. STS scholars offer a conceptualisation of ‘translation’
hat is different to those commonly used in health policy literature
20,21]. Much of this conceptualisation is grounded in what Callon
22] calls ‘sociology of translation’ and which later became known
s actor-network theory [23]. According to this conceptualisation,
nowledge translation can be seen as a process of (political) activ-
ties by which actors actively displace and transform knowledge
24]. From such an understanding, translation is about negotiation,
ransformation, and the associations between actors through which
etworks are built and extended [23]. The strength of this under-
tanding is that it offers an in-depth understanding of the active role
f potential knowledge users in translation, the work that is neces-
ary to make knowledge usable, the role of non-human actors (e.g.
aterial environments), and a speciﬁc conceptualisation of the role
f context in translating knowledge into action [17,25].
A theoretical aspect that remains underexplored in the literature
n stakeholder engagement is how stakeholders themselves envi-
ion translation of knowledge into action [26]. In particular a focus
n potential users and the role they play in shaping knowledge
se could increase understanding of how stakeholder engagement
ffects knowledge translation processes. Stakeholders’ perspec-
ives on translation of study ﬁndings into action can offer insight
nto the world in which the ﬁndings might be used, including nec-
ssary roles and responsibilities. Stakeholders can bring forward
ifferent accounts of the future world, with different roles and
esponsibilities [27].
To scrutinise how stakeholder engagement in knowledge pro-
uction shapes the use of such knowledge in practice, this study
rospectively followed stakeholder engagement in a large research
roject funded by the European Commission (EC). The European-
tudy on Quantifying Utility of Investment in Protection from
obacco (henceforth: project) centred around the transfer of an
vidence-based tobacco return-on-investment (ROI) tool (see Box
). The project explicitly planned to engage with stakeholders to
ncrease the project’s ‘impact’ [28]. The case-study at hand was
art of the parallel Stakeholder Engagement in EQUIPT for Impact
SEE-Impact) study. Our aim was to envision how stakeholder
ngagement shapes the translation of the ROI tool into action
y mapping how stakeholders themselves put forward scenarios
bout the potential use of the ROI tool. It is anticipated that the
ndings of this study will contribute to the development of stake-
older engagement in research as a method for supporting research
se.
. MethodsFor this in-depth case-study, we drew on data from 21 ethno-
raphic interviews in Hungary and the Netherlands that were
onducted as part of the SEE-Impact study. These two  countries
ere part of the four countries (i.e. Hungary, the Netherlands, Spain,The SEE-Impact study collected data through literature review,
surveys, semi-structured interviews, and observations.
and Germany) to which the European research project aimed to
transfer their tobacco ROI tool. For the purpose of our study, we
selected Hungary and the Netherlands as contrasting cases [29].
These countries have very diverse socioeconomic and political con-
texts relevant to health policy. Particularly relevant to this study
is the countries’ difference in tobacco policies and smoking preva-
lence [30,31]. At the time of this study, Hungary had more stringent
tobacco control policies than the Netherlands, but a higher smok-
ing prevalence [32,33]. More information on the SEE-Impact study
and its methods can be found elsewhere [9].
2.1. Interviewees
We  sampled stakeholders with different levels of engagement.
The ﬁrst group of stakeholders concerned partners of the EQUIPT
project. The second group consisted of actors that were invited by
the EQUIPT project to provide input in the continued development
of the tool. The ﬁnal group included actors who could have been
approached by the EQUIPT researchers (i.e. they belonged to sim-
ilar networks as the second group), but with whom no interaction
had occurred. We selected the ﬁnal group of actors based on their
substantive experience in tobacco control or health policy within
each country.2.2. Data collection and analysis
A total of 21 interviews with eight Hungarian and eleven Dutch
stakeholders were conducted. The interviewees were mostly aca-
R.A.J. Borst et al. / Health Polic
Box 2: Description of actor-scenario mapping as an
approach to studying the use of knowledge
Actor-scenario mapping
Building on Michel Callon’s notion of ‘actor worlds’ [24], we
use the concept ‘actor-scenario’ to refer to the process of
actors implicitly or explicitly putting forth scenarios about
practices in a future world [27,34]. An actor-scenario can be
seen as a relational description of potential practices, roles,
and responsibilities. Actor-scenarios are ﬁctive at ﬁrst, but
performative as well since they include descriptions of what
should happen for the scenarios to be enacted [35,36]. The
practice of scenario-building works as ongoing negotiation
process through which actors aim to effectuate change [24,37].
Researchers, for instance, constantly put forth implicit or
explicit accounts of the role that their ﬁndings should play in a
future world.
Different actors may construct different scenarios that each
portray their own roles and responsibilities. Some parts of the
scenarios might overlap, whereas others diverge. The actors
that are enrolled in the scenarios can also refute their role and
produce a different scenario with other roles and responsibil-
ities. One of such roles might be reserved for knowledge, for
instance to strengthen a scenario or weaken scenarios of oth-
ers [34]. Mapping the actor-scenarios of the stakeholders in the
EC-funded project may  explicate who the stakeholders think
should use the tool, how the tool should be used, and under































iscenario mapping’ as an approach to envision and describe
possible translations of the ROI tool into action.
emics working in health policy, health technology assessment, or
pidemiology (n = 10), followed by government ofﬁcials and parlia-
entarians (n = 5), and clinicians (n = 4).
We  used a theoretical framework (see Box 2) to guide the ethno-
raphic interviews. In particular, we developed topic lists that
peciﬁcally sought to map  actor-scenarios by asking interviewees
o think of how the tool would be used in the future and who would
lay a role in that use. This approach added some structure to the
nterviews, but allowed for a subjective, anticipatory, exploration of
opics that did not directly align with the concept of actor-scenarios
37]. During data collection, three topics that were regularly men-
ioned in the scenarios were added to the lists (i.e. decentralisation
f public services, earlier experience with stakeholder engagement,
nd politics). All interviews were audio recorded and the interview-
rs kept detailed notes during the interviews. Immediately after
ach interview, reﬂectional memos  were prepared and recordings
ere transcribed verbatim.
The process of data collection and analysis was  conducted itera-
ively. This approach allowed the researchers to identify emerging
hemes suitable for subsequent ﬁeldwork. Actor-scenario map-
ing uses an abductive sequence of analysis that requires constant
hifting between theory and empirical ﬁndings [38]. The aim is
o synthesise the different scenarios and offer thick descriptions
f potential translations, including the different envisioned roles
nd responsibilities. The potential translations in this study were
rrived at through repeated in-depth coding sessions with all team
embers.
.3. Research ethics
The data collection of this study adhered to the Decla-
ation of Helsinki and ethical clearance was obtained from
ingston University London’s Faculty Research Ethics Committee
FREC 2014/01/011). Accordingly, the researchers obtained written
nformed consent of the interviewees and the interviewers explic-
tly stated that the anonymised results would be published.y 123 (2019) 917–923 919
2.4. Study schedule
This study was  conducted between February 2015 and March
2017. The data collection was carried out between April 2015 and
September 2016.
3. How stakeholders envisioned the tool to be used
The envisioned uses of the tool were situated and shaped by
local-speciﬁc dynamics and elements of context. Conventional
with actor-network theory, we  will provide separate descriptive
accounts of how Hungarian and Dutch interviewees envisioned the
use of the tool. We  will start each section with describing the roles
and responsibilities put forth by the stakeholders, followed by what
the stakeholders described as potential enabling or constraining
elements of context in the use of the tool.
3.1. The potential users in Hungary
The actor-scenarios of Hungarian stakeholders were often quite
similar. The Hungarian stakeholders, for example, all designated
the National Focal Point for Tobacco Control a role as user. The
focal point, they described, would be a suitable user because of
their experience with economic evaluations and embeddedness
within the ofﬁcial health system. Several of the interviewees spoke
of a speciﬁc person within the focal point. They described how
this person could use the tool to compare interventions on their
cost-effectiveness, and how “he feeds the Ministry with his data.”
(Clinician 1).  They also stressed the importance of the focal point
being appointed by the government. This – combined with the
focal point’s status as WHO  partner ofﬁce – would legitimise their
recommendations amongst policymakers.
Some stakeholders assigned the National Institute of TB and
Pulmonology a role in their scenarios. An interviewee working at
the National Public Health and Medical Ofﬁcer’s Service (ÁNTSZ)
described that they did a lot of their smoking cessation activities
together with the National Institute. The interviewee described that
the National Institute is very active in this ﬁeld and would likely
be interested in the tool. When we asked one of the Institute’s
employees whether they would use it, the interviewee said that
they “would tell about it [the tool] and (. . .)  would teach with it.”
(Clinician 1)
In addition, stakeholders commonly mentioned the National
Health Insurance Fund. While nearly all respondents assigned the
Fund some role in their scenarios, they articulated different respon-
sibilities. An epidemiologist spoke of the Fund as the “most likely
user” and described that the Fund could use the tool’s output as
“ammunition to argue for some services to be reimbursed”. A clinical
professor argued that the Fund may  use an efﬁcacy comparison of
smoking cessation programmes, although this would still be “a bit
further away from their focus”. Others explained that the Fund could
provide ﬁnancial data but would otherwise not be interested in
tobacco issues. The scenario of a former Fund employee resembled
scepticism about the Fund’s responsibilities:
“They would, directly, not be interested; even if ofﬁcially they need
to be interested. (. . .)  Frankly, they are going to have a new inter-
vention that would need to be reimbursed. So, their budget will be
lower. (. . .)  In case it is cost-saving; then it is ﬁne. But, that will
probably not happen. It will not be cost-saving.” (Academic 1)Few interviewees mentioned the Secretariat of Health as a pos-
sible user of the tool. Those who  did, described that policymakers
inside the Secretariat could use the tool to prioritise their decisions
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.2. Envisioned translation in Hungary
Throughout the interviews in Hungary, a pattern emerged
howing how elements of context would enable or constrain the
otential use of the tool. Most interviewees articulated identical
lements of context, commonly referring to the newly enacted
obacco legislation of 2012. A respondent that was involved in writ-
ng the 2012 legislation, explained the strategic work necessary to
stablish it:
“We  calculated: it was December, the ﬁrst time that we could reach
the Parliament would be mid-April. We  did not trust our system–in
a way that this voice went out early on last time. So, we did the
professional work–the planning of the law–and then the State Sec-
retary discussed it inside the Parliament. What happened was that
the law, planned and written, was given to Parliament where a
group of parliamentarians said together:‘we are from the leading
party and we think it is a very important public health problem in
Hungary, we must change it, now!’And in two weeks’time, it was
voted on. That was probably the only law, in the light of years,
where left wing and right wing, whatever wing, they all voted. And
it was  something close to a ninety percent positive vote.” (Clinician
1)
Several respondents explained that with the legislation’s enact-
ent, tobacco retail was restricted, smoking in conﬁned spaces
rohibited, and excise taxes were increased. They stated that there
s no need for a ROI tool, as there is barely room left for additional
nterventions.
“If you evaluate the actual situation in Hungary, we achieved prac-
tically everything. There is no space. So, we are at the top, if related
to legislation. But, there were some concerns that your private car
is a conﬁned space.” (Clinician 2)
Another dynamic that some of the interviewees mentioned was
he decentralised and segmented government. The respondents
llustrated that there is a tension between two organisations both
perating at the local level. On the one hand, there are the county
ublic health departments, run by the county government ofﬁces
nd directed by the Prime Minister’s Ofﬁce; on the other hand, there
re the municipal health promotion ofﬁces administered by the
NTSZ on behalf of the Secretary of Health. One of the respondents
xplained that these organisations’ similar responsibilities cause
egular tensions.
“They are separated and there are conﬂicts. Because, they are work-
ing on similar issues. The conﬂicts are because they don’t really like
each other to work on the same issue.” (Government ofﬁcial 1)
Additionally, several participants described that the tool’s use
ight be constrained by the prominent place tobacco agriculture
akes in Hungary. They described that the Ministry of Agricul-
ure has a prevailing role in Hungarian policymaking. Besides, this
inistry’s main interest would be the tobacco cultivation in the
orth-Eastern part of Hungary.
“The Ministry of Agriculture, for example, is very much opposed to
regulating tobacco. Because they think that, I do not know, these
few thousand people should grow tobacco and nothing else. I never
understood why not to grow paprika instead, but okay.” (Academic
2)
Another respondent explained that it is a concurrence of sev-
ral circumstances that complicates the translation of evidence into
nti-tobacco policies. The interviewee described how actors such as
he educational system, soil, precipitation, temperature, and money
osition themselves as “tobacco allies” and constrain the enactment
f anti-tobacco policies.y 123 (2019) 917–923
“Tobacco policy depends practically on the agricultural tradition of
the country. So, you need a special soil to grow tobacco, and the
special circumstances related to temperature, precipitation, and so
on. The best region for tobacco plantations in this country is the
least-developed part, namely: The North-Eastern part.” (Clinician
2)
An element that appeared to be linked to the tobacco agricul-
ture was Hungary’s history of communism. A former politician
explained that excessive smoking was  a common habit during the
Soviet era. During service in the Red Army, the respondent would
receive a daily amount of 15 cigarettes regardless of whether one
smoked or not. These cigarettes would be supplied by State-run
tobacco plantations as part of the planned economy. After the fall
of communism, the proprietorship was transferred to the corporate
tobacco industry. The interviewee said that it was only by then that
the medical community ﬁrst initiated an anti-tobacco community
with the philosophy to reduce tobacco-related harm.
Stakeholders in Hungary regularly spoke of the same actors in
their scenarios about the potential use of the tool. Some stakehold-
ers constructed slightly different scenarios. Overall, there seemed
to arise convergence in stakeholders’ narratives about enabling and
constraining dynamics in the potential use of the tool.
3.3. The potential users in the Netherlands
Unlike in Hungary, the actor-scenarios of Dutch stakeholders
showed divergence. Interviewees described that the tool would not
be used at all, or that its use would be constrained by what was
referred to as ‘the political climate’. Sometimes participants men-
tioned speciﬁc organisations, but usually expressed uncertainty as
to whether these organisations would actually use the tool. All
interviewees assigned ‘policymakers’ a role in their scenarios, but
without specifying who  this actor is in practice. While some scenar-
ios were more speciﬁc, most stakeholders did not articulate what
the role and responsibility of policymakers speciﬁcally would be.
Interviewees commonly said that the municipal government
and Municipality Health Service (GGD) would play a role. One pro-
fessor in health policy explained that the municipal government
might use the tool to guide their service procurement. Two tobacco
control experts, however, described that anti-tobacco incentives
are not the municipality’s priority; their political accountability
causes them to prioritise less sensitive issues. The experts described
that the municipal governments do not allocate the GGDs any anti-
tobacco related tasks and that the GGDs do not have the resources
to carry out anti-tobacco activities themselves. Even if they had,
they would not have the expertise to use ROI tools for it, as one
governance scholar explained.
Several respondents mentioned the National Institute for Pub-
lic Health and Environment (RIVM) as a potential user. The RIVM
functions as advisory body to the government. One interviewee
explained that the RIVM as potential administrator could store the
tool and update it if necessary. Two  interviewees clariﬁed that the
RIVM used to deploy similar tools to answer tobacco control ques-
tions raised by the Ministry of Health. An interviewee formerly
active in tobacco control shared an article that showed how the
RIVM used to produce ‘scenarios’: predictions of the impact that
certain combinations of anti-tobacco interventions could have.
“It was not a tool in which everyone could twist the knobs, it was
quite complex. (. . .)  So, all these scenarios were already there. (. . .)
Because, back then, the Ministry still gave the RIVM such orders.”
(Academic 3)
An interviewee working at the RIVM claimed to recognise that
they no longer receive any orders from the Ministry to estimate the
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“The assumption of this European tool is that policymaking is
mainly motivated by rational considerations; whereas in practice,
that is obviously not the case. Such a tool could help to stimulate
this, that makes sense. But, I am not sure whether the RIVM would
use it to answer questions of the Ministry. That would mean that
there is a situation in which a policymaker, at local or national level,
says:‘we want to discourage the use of tobacco, this is the amount
of funding, these are the conditions, now what would be the most
efﬁcient use of our resources?’Well, that is a laboratory situation
that will never happen in practice.” (Government ofﬁcial 2)
The interviewees disagreed on the role that researchers could
lay. One academic said that academic researchers would use the
ool to evaluate the cost-effectiveness of interventions. Some of
he project members planned for academics to adapt and update
he tool. Two public health academics spoke of researchers at a
ational institute for mental health and addiction using the tool for
onitoring. Nearly all interviewees, however, described that this
ctivity would be a bit further from the institute’s core focus – since
obacco control is not included in their mandate.
Respondents often articulated generic ideas of who  might be
nterested or capable in using the tool. Occasionally, these ideas
ere refuted by other respondents. Overall, there appeared to be
ultiple deviating scenarios about the potential use of the tool. The
ikelihood of the scenarios to be translated into action seemed to be
ffected by dynamics in the countries’ context. The elements that
ere mentioned by the respondents are portrayed in the subse-
uent sections.
.4. Envisioned translation in the Netherlands
An element that prevailed in the scenarios of Dutch actors was
he political climate. The majority of Dutch interviewees referred to
wo acts of the then Minister of Health in 2010. The ﬁrst being her
mphasis on ‘de-patronisation’ with regard to anti-tobacco legisla-
ion. The second act was the Minister’s repeal of the smoking ban for
mall restaurants and bars. One interviewee clearly remembered
he Minister’s position on tobacco control:
“We  went to the Ministry in 2010 and offered the Minister a petition
against tobacco, with over 1000 signatures. So, we visited her and
she said:‘well, I really think this [smoking] is a free choice and I am
not so fond of statistics.’That is what she said in that conversation.
[raising voice]” (Clinician 3)
Interviewees often spoke of the closing of the national expertise
entre on tobacco control in 2013. A former employee explained
hat the Ministry of Health suspended its funding by 2011. Subse-
uently, the health foundations, responsible for the other half of the
unding, decided to independently proﬁle themselves more actively
n tobacco control. The ex-employee explained that some of the
ctivities were transferred to other organisations. Nonetheless, the
ajority of the centre’s promotional activities were abandoned and
t remains unclear who should ﬁll that gap.
While the respondents tried to identify potential users of the
ool, they said that it is actually quite unclear who  governs tobacco
ontrol in the Netherlands. One local government ofﬁcial explained
hat the Ministry of Health stipulates quadrennial national pre-
ention priorities that should guide the municipal governments in
rioritising at the municipal level. The municipality would then be
fﬁcially responsible for the execution of prevention. But, several
nterviewees expressed that tobacco prevention might not be the
unicipalities’ uppermost priority.
When we asked whether politics would play a role, nearly all
ctors referred to political incentives. A Member of Parliament for
he Labour party described that tensions within the then minority
abinet would prevent future anti-tobacco interventions from gain-y 123 (2019) 917–923 921
ing traction. According to the interviewee, anti-tobacco policies
do resonate within the Labour party, but the coalition agreement
refrains them from acting. Other interviewees – who  used to work
on tobacco control for a longer period – seemed sceptical: they
indicated that Parliamentarians would focus on increasing the gov-
ernment budget within the four-year cycle, and tobacco-control
does not ﬁt that agenda.
“The current political landscape is fragmented and there is no
majority for a more stringent policy on smoking. (. . .)  There are
actually two opposed sides: the conservative-liberalist side on
which it is a freedom of choice, and the socio-democratic that says:
tobacco is a perverse incentive of the government to complement
the treasure chest.” (Parliamentarian)
Finally, the respondents often spoke of a recent history full with
major health system reforms. An interviewee believed that these
left little room for further tobacco control legislation. The intervie-
wee explained that the former Minister of Health implemented the
ban on smoking in conﬁned spaces and major reforms of the public
health law. The interviewee’s predecessor completely reformed the
healthcare system, whereas currently the focus is on redistributing
power between health insurers and medical professionals. Anti-
smoking did not have place on the political agenda.
4. Discussion
This study aimed to explore how stakeholder engagement
in knowledge production shapes the use of such knowledge in
practice. In order to explore this, we  studied engagement of
stakeholders in the continued development of a tobacco control
return-on-investment tool. We asked the stakeholders to put forth
an explicit scenario about which actors would use the tool and
under which circumstances the tool could be used. Most stake-
holders described that they found it difﬁcult to identify potential
users of the tool. While most stakeholders envisioned quite a local-
speciﬁc scene, they set the stage with exceedingly generic potential
users and responsibilities. An example was that most Dutch inter-
viewees spoke of ‘policymakers’ as potential users of the tool but
were mostly unable to identify these actors in practice.
Our mapping of actor-scenarios offers three observations rel-
evant to stakeholder engagement in knowledge production. First,
we have introduced a speciﬁc understanding of stakeholders’ role in
knowledge production. We  showed how stakeholders have implicit
or explicit understandings of how, by whom,  and under which cir-
cumstances, the produced knowledge may  be used, or what makes
the produced knowledge relevant and usable. By engaging the
stakeholders, these renderings of a future world will start interact-
ing with the scenarios of the knowledge producers, who themselves
inscribe their produced knowledge with assumptions about the cir-
cumstances under which the produced knowledge may be used
[34,39]. It is these interactions that will shape to some extent how
the knowledge may  be translated into action. This can be espe-
cially challenging when the actor-scenarios of stakeholders seem
to diverge, as was the case in the Netherlands. The diverging actor-
scenarios may  induce disputes over how these diverse inputs of
stakeholders will be treated in the production of knowledge or who
will be ‘the user’ of the produced knowledge [14,19].
A second observation is that actor-scenario mapping can pro-
vide an empirical understanding of what knowledge use entails in
practice. In particular, our approach reiterates that knowledge in
itself does not have a univocal value, but requires active work in
order to become ‘usable’. This work involves a clear articulation
of what roles and responsibilities the knowledge requires. In the
Netherlands for example, the stakeholders of the European project
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ng to the interviewees, such an actor would be a prerequisite in the
se of the tool. They explained that without this governing actor, it
ould be impossible to act upon the knowledge. Similarly, the Hun-
arian respondents constituted the focal point for tobacco control
y describing how it would have to become the key user of the tool.
A ﬁnal observation to consider is how actor-scenario map-
ing contributes to our understanding of the role of context in
nowledge translation. Our ﬁndings show how actors constructed
ontext by bringing forth a scenario of roles and responsibilities.
his implies that context is not something clearly deﬁned and ﬁxed,
ut instead refers to a ﬂuid and contingent network of elements
40]. In their scenarios, the stakeholders described that some actors
nd dynamics would constitute ‘contexts’ that could enable or con-
train the use of the tool [41]. Dutch interviewees for instance
poke of the then Minister of Health, local governments, and his-
orical legislative reforms. Stakeholders in Hungary would refer
o the soil, precipitation, and a history of communist-rule that all
onstrain tobacco control. In their scenarios, the stakeholders con-
tructed a ﬂuid boundary between content and context to account
or a difference between use and that what shapes potential use,
nd subsequently mobilised the actors they designated as context
17,42].
Several questions about stakeholder engagement in knowledge
roduction remain. A ﬁrst question is what the convergence or
ivergence of different actor-scenarios means. In Hungary, the sce-
arios appeared to be more speciﬁc and converging than in the
etherlands. The data suggest that some actors are embedded
nd entangled in networks in different ways; potentially relating
ore to local-speciﬁc actors [24]. Conversely, an understanding of
ivergence might be found in the generic user descriptions (e.g. pol-
cymaker). Shove & Rip suggest that the use of such universal labels
esults in a mismatch with the roles that actors construct in practice
43]. Although the stakeholders might all consider the policymaker
o be a primary user, their identiﬁcations of this actor in practice
re likely to differ. This contradiction creates a problem of transla-
ion when this generic notion of users is inscribed in the produced
nowledge [19]. It has been described before how these inscrip-
ions have performative effects: the inscription could for instance
mpair use by anyone other than this generic user [35,44]. Lastly, it
s important to note here that in the UK, where the development of
he ROI tool ﬁrst originated, engagement with stakeholders – being
ctors with an explicit stake in both the development and use of
he tool – had been a key element of the success of the project. This
bservation has implications for the nature of stakeholder engage-
ent in research – in particular in so far stakeholder engagement
s concerned as means to increase research use [45].
In this study we developed actor-scenario mapping as approach
o studying knowledge translation practices. The notion of actor-
cenarios has been used before and is embedded in a wider
iterature on scenario-building, ﬁctive scripting, and the construc-
ion of actor-worlds [24,27,37,46]. We  further developed the notion
f actor-scenarios into an approach to envision knowledge transla-
ion practices more generally. What distinguishes actor-scenario
apping from other analytical approaches, including thematic
nalysis and a constant comparative method, is its emphasis on
bduction, sensitivity to the sociomaterial environments, and focus
n mobilisation of contextual elements [27,38,47,48]. Additionally,
he approach recognises the situated nature of both the actor that
uts forth the scenarios, and the scenarios themselves. An element
f actor-scenario mapping that needs to be developed further is
ts capacity to guide translation of knowledge into action. In other
ectors, scenarios of the future are often used to plan or anticipate
hese possible futures. While we recognise the inherent contingen-
ies in knowledge translation, it may  be possible to productively
se actor-scenario mapping in existing stakeholder mapping exer-
ises. The scenarios could be used as input to research projects. Iny 123 (2019) 917–923
the example of the European research project, the scenarios may
have been used to align the knowledge production process (i.e. con-
tinued development of the tool) with the stakeholders’ envisioned
utilisations of that knowledge.
5. Conclusion
Our analysis suggests that engaging stakeholders in knowledge
production shapes the translation of that knowledge into action
in different ways. Stakeholders constantly put forth implicit or
explicit scenarios about which actors might use the knowledge, in
which way, and under what circumstances. These actor-scenarios
are ﬁctive at ﬁrst but have a performative working as well: through
their engagement, the stakeholders’ scenarios contribute to how
the knowledge is constructed and thus also what its use entails.
Actor-scenario mapping may  help in actively aligning research
processes with the translations that stakeholders envision. The
assumptions and expectations of roles, responsibilities, and poten-
tial use, explicated by mapping the actor-scenarios, could be fed
back in the research project and might help in increasing the like-
lihood that results will be used. Additionally, our data contribute
to a deeper understanding of the ‘context of use’ by showing how
actors mobilise elements of context in their scenarios, and how such
elements could enable and constrain the use of knowledge.
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